| 1 |
34907000 | Senolytic-Mediated Elimination of Head and Neck Tumor Cells Induced Into Senescence by Cisplatin. | 2022 Mar |
1 |
| 2 |
32881195 | Platycodin D suppresses cisplatin-induced cytotoxicity by suppressing ROS-mediated oxidative damage, apoptosis, and inflammation in HEK-293 cells. | 2021 Jan |
1 |
| 3 |
34088830 | Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. | 2021 Aug |
1 |
| 4 |
34111459 | Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. | 2021 Sep 1 |
2 |
| 5 |
34322387 | Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells. | 2021 |
1 |
| 6 |
31648572 | Radiosensitizing Potential of Curcumin in Different Cancer Models. | 2020 |
1 |
| 7 |
32945500 | Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin. | 2020 Oct |
1 |
| 8 |
31262032 | Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study. | 2019 Jun 30 |
3 |
| 9 |
31462500 | Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer. | 2019 Nov |
2 |
| 10 |
31754340 | RMP/URI inhibits both intrinsic and extrinsic apoptosis through different signaling pathways. | 2019 |
1 |
| 11 |
29203930 | Downregulation of liver-intestine cadherin enhances cisplatin-induced apoptosis in human gastric cancer BGC823 cells. | 2018 Feb |
1 |
| 12 |
29352235 | Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells. | 2018 Jan 19 |
1 |
| 13 |
30032449 | Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation. | 2018 Oct |
2 |
| 14 |
28597042 | Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. | 2017 Aug |
3 |
| 15 |
28617432 | BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer. | 2017 Jun 15 |
1 |
| 16 |
28963947 | ABT737 induces mitochondrial pathway apoptosis and mitophagy by regulating DRP1-dependent mitochondrial fission in human ovarian cancer cells. | 2017 Dec |
1 |
| 17 |
28979680 | Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy. | 2017 |
1 |
| 18 |
29262633 | Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun. | 2017 Nov 28 |
1 |
| 19 |
26860078 | β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl. | 2016 Mar |
2 |
| 20 |
27015836 | Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents. | 2016 Aug |
1 |
| 21 |
27127878 | FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression. | 2016 Jun 7 |
2 |
| 22 |
27226901 | Cdk2 phosphorylation of Bcl-xL after stress converts it to a pro-apoptotic protein mimicking Bax/Bak. | 2016 |
2 |
| 23 |
27494891 | Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells. | 2016 Aug 30 |
1 |
| 24 |
25310746 | The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL. | 2015 Jan |
2 |
| 25 |
25992654 | The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. | 2015 |
1 |
| 26 |
26201840 | Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells. | 2015 Sep |
1 |
| 27 |
26239225 | MicroRNA‑133a and microRNA‑326 co‑contribute to hepatocellular carcinoma 5‑fluorouracil and cisplatin sensitivity by directly targeting B‑cell lymphoma‑extra large. | 2015 Oct |
2 |
| 28 |
26497680 | Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2. | 2015 Dec 8 |
2 |
| 29 |
26592553 | MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma. | 2015 Nov 23 |
3 |
| 30 |
24286513 | Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines. | 2014 Feb |
1 |
| 31 |
24637722 | CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma. | 2014 |
2 |
| 32 |
23027129 | RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. | 2013 Aug 22 |
1 |
| 33 |
23188704 | Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells. | 2013 Apr |
1 |
| 34 |
23665025 | Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. | 2013 May 31 |
1 |
| 35 |
23912708 | Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells. | 2013 Oct |
1 |
| 36 |
23969971 | Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer. | 2013 Aug |
1 |
| 37 |
24400442 | Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL. | 2013 Dec |
1 |
| 38 |
22267549 | Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs. | 2012 Mar |
1 |
| 39 |
22431999 | Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. | 2012 |
1 |
| 40 |
22445428 | Cisplatin induces platelet apoptosis through the ERK signaling pathway. | 2012 Jul |
1 |
| 41 |
22983390 | Migfilin sensitizes cisplatin-induced apoptosis in human glioma cells in vitro. | 2012 Oct |
1 |
| 42 |
21052098 | Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells. | 2011 Mar |
1 |
| 43 |
21252285 | Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells. | 2011 Mar |
1 |
| 44 |
21863213 | The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. | 2011 |
3 |
| 45 |
22033921 | The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation. | 2011 Dec 23 |
1 |
| 46 |
19634140 | Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. | 2010 Feb 15 |
3 |
| 47 |
20142415 | Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. | 2010 Jun |
2 |
| 48 |
20372863 | ARL6IP1 mediates cisplatin-induced apoptosis in CaSki cervical cancer cells. | 2010 May |
3 |
| 49 |
20400521 | The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival. | 2010 Jun 1 |
1 |
| 50 |
20451370 | Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy. | 2010 Jun |
1 |